RecruitingNot applicableNCT06040905

Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chung Shan Medical University
Principal Investigator
Ping-Ting Lin, Ph.D.
Chung Shan Medical University
Intervention
Coenzyme Q10(dietary_supplement)
Enrollment
100 target
Eligibility
50-80 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Collaborators

National Science and Technology Council

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06040905 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials